Molecular mechanisms of erbB2-mediated breast cancer chemoresistance.
DOI: 10.1007/978-0-387-74039-3_9
关键词: Receptor tyrosine kinase 、 Epidermal growth factor receptor 、 Oncology 、 Cell signaling 、 ErbB Receptors 、 Cell biology 、 ERBB3 、 Receptor 、 Tyrosine kinase 、 Internal medicine 、 Ligand (biochemistry) 、 Chemistry
摘要: The erbB2 (also known as HER2 or neu) gene encodes a 185-kDa transmembrane glycoprotein, which belongs to the epidermal growth factor receptor (EGFR) family. ErbB2 is a …
springer.com
springerlink.com参考文章(95)
Berezov A, Zhang H, Greene Mi, Richter M, Cheng X, Furuchi K, Murali R, Liu Q, Antibody like peptidomimetics as large scale immunodetection probes. Cellular and Molecular Biology. ,vol. 49, pp. 209- 216 ,(2003)
Antonina S. Rait, Kathleen F. Pirollo, Laiman Xiang, David Ulick, Esther H. Chang, Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels. Molecular Medicine. ,vol. 8, pp. 475- 486 ,(2002) , 10.1007/BF03402027
Richard A. Stein, James V. Staros, Evolutionary Analysis of the ErbB Receptor and Ligand Families Journal of Molecular Evolution. ,vol. 50, pp. 397- 412 ,(2000) , 10.1007/S002390010043
C. L. Shapiro, I. C. Henderson, D. F. Hayes, Treatment of metastatic breast cancer: present and future prospects. Seminars in Oncology. ,vol. 22, pp. 5- 21 ,(1995)
Ming Tan, Mien Chie Hung, Dihua Yu, Bolin Liu, Shan Shue Wang, Junzhi Li, Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene. ,vol. 13, pp. 1359- 1365 ,(1996)
Cun-Yu Wang, James C. Cusack, Rong Liu, Albert S. Baldwin, Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB Nature Medicine. ,vol. 5, pp. 412- 417 ,(1999) , 10.1038/7410
Gaetano Finocchiaro, Cristiana Giani, Mutation Rate of the CDKN2 Gene in Malignant Gliomas Cancer Research. ,vol. 54, pp. 6338- 6339 ,(1994)
M.J. Mihatsch, F. Gudat, F. Waldman, D. Moore, P. Carroll, G. Sauter, H. Moch, R. Kerschmann, K. Chew, Heterogeneity of erbB-2 Gene Amplification in Bladder Cancer Cancer Research. ,vol. 53, pp. 2199- 2203 ,(1993)
Belén Lloveras, Ramon Colomer, Belén Ojeda, Ana Lluch, Bartomeu Massutí, Agustí Barnadas, Hernán Cortés-Funes, Antonio Casado, Sagrario Montero, Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer. Clinical Cancer Research. ,vol. 6, pp. 2356- 2362 ,(2000)
R. Pinkas-Kramarski, L. Soussan, H. Waterman, G. Levkowitz, I. Alroy, L. Klapper, S. Lavi, R. Seger, B. J. Ratzkin, M. Sela, Y. Yarden, Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. The EMBO Journal. ,vol. 15, pp. 2452- 2467 ,(1996) , 10.1002/J.1460-2075.1996.TB00603.X